SAGIMET BIOSCIENCES INC-A (SGMT)
US7867001049 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to SGMT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.25. This target is 828.83% above the current price.
SGMT was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SGMT.
In the previous month the buy percentage consensus was at a similar level.
SGMT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-15 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-01 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-07 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-02 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-26 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-03-25 | Leerink Partners | Initiate | Outperform |
| 2024-02-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-01-23 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-01-23 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-22 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-12-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-08 | TD Cowen | Initiate | Outperform |
| 2023-08-08 | JMP Securities | Initiate | Market Outperform |
| 2023-08-08 | Goldman Sachs | Initiate | Buy |
| 2023-08-08 | Piper Sandler | Initiate | Overweight |